Posted on 09/06/2009 in Pharmaceutical Company Product News Lilly's sponsored project has saved some $95 million (58.86 million pounds) in medication costs for those with behavioural health problems.
Designed and run by research organisation Comprehensive NeuroScience, the scheme was called the Behavioural Pharmacy Management Programme.
The aim of it was to educate physicians and medical practices about the best alternative treatments available.
As a result of its success so far, the programme has won a number of accolades, including the Substance Abuse and Mental Health Services Administration Science and Service Award.
Dr Joseph Parks is from the Missouri Department of Mental Health, a division that took part in the scheme.
He noted improving standards and lowering prices in healthcare is a complex issue.
"These kinds of partnerships, which pursue quality as a way to contain costs, are really going to be the solution to a lot of the health care problems that ? [we] face," Dr Parks commented.
Meanwhile, Lilly recently announced some organisational changes. The company appointed Bart Peterson as its senior vice-president of corporate affairs and communications. Other news stories from 09/06/2009
Read more in the Zenopa News Archive
How this news is generated
|
